• Explore /
  • Poster
  • / Prognostic value of O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT) status in pancreatic neuroendrocrine tumors with capecitabine and temozolomide (CAPTEM).

Prognostic value of O6-methylguanine-DNA methyltransferase (MGMT) status in pancreatic neuroendrocrine tumors with capecitabine and temozolomide (CAPTEM).

Abstract Video & Slides Poster

Authors

null

Eduardo Terán Brage Sr.

Hospital Universitario de Salamanca, Salamanca, Spain

Eduardo Terán Brage Sr., Jorge Feito Pérez Sr., Luis Miguel Navarro Martín Sr., Roberto Andrés Escala Cornejo Sr., María Mar Abad Hernández , Sofía Del Carmen , Álvaro López Gutiérrez Sr., Belén Cigarral García , Rosario Vidal Tocino , Rebeca Lozano , Emilio Fonseca Sánchez Sr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 598)

DOI

10.1200/JCO.2024.42.3_suppl.598

Abstract #

598

Poster Bd #

H9

Abstract Disclosures

Similar Posters

First Author: Pamela L. Kunz

First Author: Alex Ganetsky

First Author: Nick Pavlakis

Poster

2019 ASCO Annual Meeting

Retrospective study of capecitabine and temozolomide in advanced lung neuroendocrine neoplasms.

Retrospective study of capecitabine and temozolomide in advanced lung neuroendocrine neoplasms.

First Author: Taymeyah E. Al-Toubah